Chronic Kidney Disease (CKD) Supportive Care Protocol

RenalModerate Evidence

supplements

Primary

Supporting

Grade A

Studies

Primary Stack

Core supplements with strongest evidence

Omega-3 Fatty AcidsB

2-4g EPA/DHA daily

Reduces inflammation, protects against cardiovascular complications, and may slow kidney function decline

↓Inflammation↓Weight

18 studies1,500 participants

Supporting Studies (2)

PMID: 29566106 - Omega-3 fatty acids in CKD: meta-analysis (2018)PMID: 28647416 - Fish oil and kidney disease progression (2017)

Coenzyme Q10B

100-300mg daily

Supports mitochondrial function, reduces oxidative stress, and may improve kidney function markers

↓Blood glucose↑Kidney Function↑High-density lipoprotein (HDL)↓Total cholesterol↓Triglycerides

8 studies450 participants

Supporting Studies (1)

PMID: 31203755 - CoQ10 supplementation in CKD: systematic review (2019)

Supporting Stack

Additional supplements for enhanced results

Vitamin DA

1000-4000 IU daily (or as prescribed active form)

Addresses deficiency universal in CKD, supports bone health, and may reduce proteinuria

Calcium ScoreHigh-density lipoprotein (HDL)Free Testosterone↑Osteocalcin↓Low-density lipoprotein (LDL)

25 studies2,000 participants

Supporting Studies (1)

PMID: 29507048 - Vitamin D in CKD: KDIGO guidelines update (2018)

ProbioticsB

10-50 billion CFU daily (specific CKD strains)

Reduce uremic toxins by modulating gut microbiome and may lower inflammation

15 studies800 participants

Supporting Studies (1)

PMID: 30591744 - Probiotics in chronic kidney disease: meta-analysis (2019)

How This Protocol Works

Simple Explanation

Chronic Kidney Disease means the kidneys are gradually losing their ability to filter waste and excess fluid from the blood. CKD dramatically increases cardiovascular risk and causes numerous complications including anemia, bone disease, and accumulation of toxins. While supplements cannot reverse kidney damage, they can address complications and may slow progression.

•Omega-3 Fatty Acids help protect the heart—critical since cardiovascular disease is the leading cause of death in CKD. They reduce inflammation (elevated in CKD), improve blood lipids, and some studies suggest they may slow kidney function decline.

•Coenzyme Q10 supports cellular energy production and acts as an antioxidant. Oxidative stress is markedly elevated in CKD and contributes to complications. Studies show CoQ10 may improve kidney function markers and reduce inflammation.

•Vitamin D deficiency is nearly universal in CKD because the kidneys convert vitamin D to its active form. Deficiency contributes to bone disease, cardiovascular problems, and immune dysfunction. Supplementation is often essential but may require the active form (calcitriol) as CKD progresses.

•Probiotics address the disrupted gut microbiome in CKD. An unhealthy gut produces uremic toxins that the failing kidneys cannot clear. Specific probiotic strains can reduce these toxins and lower inflammation.

Expected timeline: Benefits develop over weeks to months with consistent use. Vitamin D should be monitored and adjusted based on blood levels.

Critical: Always work with your nephrologist. Many supplements can be harmful in kidney disease—these have been selected for safety, but dosing may need adjustment based on kidney function.

Clinical Perspective

CKD involves progressive nephron loss, uremic toxin accumulation, chronic inflammation, oxidative stress, and mineral-bone disorder. Cardiovascular disease causes >50% of deaths in CKD. This protocol addresses modifiable factors while avoiding nephrotoxic supplements.

•Omega-3 Fatty Acids (B-grade): EPA/DHA reduce inflammatory mediators elevated in CKD (IL-6, TNF-α, CRP). Improve dyslipidemia common in CKD. May reduce proteinuria via anti-inflammatory effects on glomeruli. Meta-analysis of 18 studies: modest reduction in triglycerides and inflammation (PMID: 29566106). Some evidence for slowed GFR decline in IgA nephropathy.

•Coenzyme Q10 (B-grade): Mitochondrial dysfunction and oxidative stress accelerate CKD progression. CoQ10 deficiency common in CKD patients. Systematic review: supplementation may reduce creatinine and BUN, improve eGFR, and lower inflammatory markers (PMID: 31203755). Also addresses statin-induced depletion (statins commonly used in CKD).

•Vitamin D (A-grade): 1-alpha-hydroxylase activity declines with nephron loss, causing calcitriol deficiency despite adequate 25(OH)D. Deficiency contributes to secondary hyperparathyroidism, renal osteodystrophy, and cardiovascular calcification. KDIGO guidelines recommend correcting deficiency (PMID: 29507048). Native vitamin D sufficient in early CKD; active vitamin D (calcitriol/alfacalcidol) needed in advanced CKD.

•Probiotics (B-grade): CKD gut dysbiosis increases production of uremic toxins (indoxyl sulfate, p-cresyl sulfate) via bacterial metabolism. These toxins promote cardiovascular disease and CKD progression. Meta-analysis: probiotics reduce BUN and inflammatory markers (PMID: 30591744). Strains studied: Lactobacillus, Bifidobacterium, Streptococcus thermophilus.

Biomarker targets: eGFR, proteinuria, serum creatinine/BUN, 25(OH)D, PTH, phosphorus, lipid panel, CRP.

Protocol notes: CRITICAL: Coordinate with nephrologist. AVOID: High-dose vitamin C (oxalate stones), vitamin A (accumulates), potassium/phosphorus-containing supplements in advanced CKD, NSAIDs, many herbal supplements. Vitamin D: monitor calcium and phosphorus. Fish oil: use pharmaceutical grade; no risk of mercury accumulation. Probiotics: avoid in immunocompromised. Adjust doses based on GFR. ESA and iron for anemia require Rx.

View All Protocols